Exelixis (EXEL) had the highest return between October 1, 2014 and November 30, 2015 by a large-cap US stock, returning 262%.
| ASSET | DATE | % RETURN |
|---|---|---|
Exelixis (EXEL) | 10/1/2014 - 11/30/2015 | 262.03% |
Neurocrine Biosciences (NBIX) | 10/1/2014 - 11/30/2015 | 245.43% |
Cytokinetics (CYTK) | 10/1/2014 - 11/30/2015 | 232.02% |
Genmab A-S (GMAB) | 10/1/2014 - 11/30/2015 | 204.2% |
Coca-Cola Consolidated (COKE) | 10/1/2014 - 11/30/2015 | 163.5% |
Comfort Systems USA (FIX) | 10/1/2014 - 11/30/2015 | 138.67% |
Incyte (INCY) | 10/1/2014 - 11/30/2015 | 132.48% |
Manhattan Associates (MANH) | 10/1/2014 - 11/30/2015 | 128.86% |
Frontline (FRO) | 10/1/2014 - 11/30/2015 | 119.57% |
DexCom (DXCM) | 10/1/2014 - 11/30/2015 | 113.73% |
Amazon (AMZN) | 10/1/2014 - 11/30/2015 | 106.43% |
Global Payments (GPN) | 10/1/2014 - 11/30/2015 | 102.92% |
Tyler Technologies (TYL) | 10/1/2014 - 11/30/2015 | 101.56% |
NetEase (NTES) | 10/1/2014 - 11/30/2015 | 96.96% |
Corcept Therapeutics (CORT) | 10/1/2014 - 11/30/2015 | 96.28% |
Halozyme Therapeutics (HALO) | 10/1/2014 - 11/30/2015 | 95.18% |
Netflix (NFLX) | 10/1/2014 - 11/30/2015 | 92.41% |
Palo Alto Networks (PANW) | 10/1/2014 - 11/30/2015 | 91.57% |
Trip Group Ltd ADR (TCOM) | 10/1/2014 - 11/30/2015 | 89.23% |
Lennox International (LII) | 10/1/2014 - 11/30/2015 | 80.02% |
Leidos (LDOS) | 10/1/2014 - 11/30/2015 | 76.89% |
Interactive Brokers (IBKR) | 10/1/2014 - 11/30/2015 | 76.36% |
O’Reilly Automotive (ORLY) | 10/1/2014 - 11/30/2015 | 75.95% |
NVIDIA (NVDA) | 10/1/2014 - 11/30/2015 | 75.24% |
Fair Isaac (FICO) | 10/1/2014 - 11/30/2015 | 72.42% |
Large-cap stocks are treated as having a market cap of $10B+.